We found that atorvastatin was the most effective and pravastatin was the least effective at suppressing the growth of cancer cell lines, including breast (MCF-7 RFP, MDA-MB-231 RFP, and MDA-MB-231 RFP/Ecad, Fig 1A–1C), prostate (DU-145, Fig 1D), brain (SF-295, Fig 1E), and melanoma (MDA-MB-435, Fig 1F). The gene discussed is CDH1; the disease is cancer.